PA-824, moxifloxacin and pyrazinamide combination therapy for tuberculosis
dc.contributor.author | Dawson R | |
dc.contributor.author | Diacon AH | |
dc.date.accessioned | 2014-07-07T12:26:15Z | |
dc.date.available | 2014-07-07T12:26:15Z | |
dc.date.issued | 2013 | |
dc.description | Please help populate SUNScholar with the full text of SU research output. Also - should you need this item urgently, please send us the details and we will try to get hold of the full text as quick possible. E-mail to scholar@sun.ac.za. Thank you. | |
dc.description | Journal Articles (subsidised) | |
dc.description | Geneeskunde en Gesondheidswetenskappe | |
dc.description | Geneeskundige Fisiologie | |
dc.identifier.citation | Expert Opinion on Investigational Drugs | |
dc.identifier.citation | 22 | |
dc.identifier.citation | 1 | |
dc.identifier.citation | 6 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/93494 | |
dc.publisher | ASHLEY PUBLICATIONS LTD, UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEYCENTRAL, LONDON, ENGLAND, N3 1QB | |
dc.title | PA-824, moxifloxacin and pyrazinamide combination therapy for tuberculosis |